Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer-Reference-Cited by-同舟云学术

Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer

Published:2000-01 Issue:2 Volume:36 Page:177-182
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Udom D.I.,Vigushin D.M.,Linardou H.,Graham H.,Palmieri C.,Coombes R.C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. In situ analysis of navelbine on various types of microtubules using immunofluorescence;Binet;Semin. Oncol.,1989

2. Summary of data from in vitro and phase I vinorelbine (navelbine) studies;Burris III;Semin. Oncol.,1994

3. Zhan Z, Fojo T, et al. Tubulin expression and polymerisation in normal tissues, human tumours and paclitaxel (PTx) selected ovarian and breast carcinoma cell lines. Proc Am Assoc Can Res 1994, 39, 390 (abstract 2326).

4. Experimental antitumour activity of navelbine;Cross;Semin. Oncol.,1989

5. Preclinical evaluation of docetaxel (Taxotere);Lavelle;Semin. Oncol.,1995

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized Feasibility Study of Docetaxel Versus Vinorelbine in Advanced Breast Cancer;The Oncologist;2012-09-21

2. Choosing chemotherapy for patients with metastatic breast cancer previously exposed to taxanes and anthracyclines: other agents;Community Oncology;2012-05

3. Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer;Cancer Chemotherapy and Pharmacology;2012-02-04

4. Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer;Onkologie;2012

5. Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review;The Lancet Oncology;2011-10